Trial NCT00511576

View at ClinicalTrials.gov 
Org. Study IDs: 103 PH US 2007 CL001

Last trial update was posted on 2015-01-08

MeSH Interventions

Docetaxel Mocetinostat

MeSH Conditions

Breast Neoplasms Carcinoma, Non-Small-Cell Lung Lung Neoplasms Prostatic Neoplasms Stomach Neoplasms

Other Conditions

Breast Cancer Gastric Cancer Lung Cancer Non-Small-Cell Lung Carcinoma Prostate Cancer Prostatic Cancer Pulmonary Cancer Stomach Cancer

Stopping Reasons

Celgene terminated its collaboration agreement with MethylGene for the development of MGCD0103. All Celgene-sponsored trials with MGCD0103 will be closed.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID